Spiro Medical
Develops a Pulmonary Neuromodulation System for asthma treatment
$67MSeries A
Role not disclosedSI
Supernova Invest
Activity from announced rounds
Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026
Supernova Invest is the French deep-technology manager whose own materials identify Quobly and HighLife.
Recorded funding activity
HighLife develops a transcatheter heart-valve system. Exein secures devices, while Moa discovers herbicides. Named seed funds remain separate from the manager-level history.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $67M 1 disclosed · full round size, not this investor’s share